دورية أكاديمية

Research trends and hotspots of exosomes in respiratory diseases.

التفاصيل البيبلوغرافية
العنوان: Research trends and hotspots of exosomes in respiratory diseases.
المؤلفون: Fu J; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.; College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Song W; College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Medical History and Literature Center, Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Tianjin Key Laboratory of Modern Chinese Medicine Theory Innovation and Transformation, Tianjin, China., Hao Z; College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Medical History and Literature Center, Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Tianjin Key Laboratory of Modern Chinese Medicine Theory Innovation and Transformation, Tianjin, China., Fan M; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.; College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Li Y; Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.; College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
المصدر: Medicine [Medicine (Baltimore)] 2023 Sep 29; Vol. 102 (39), pp. e35381.
نوع المنشور: Review; Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins
مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung* , Exosomes* , Lung Neoplasms* , Respiration Disorders* , Respiratory Tract Diseases* , MicroRNAs*, Humans ; China
مستخلص: Currently, theoretical studies on exosomes in respiratory diseases have received much attention from many scholars and have made remarkable progress, which has inestimable value and potential in future clinical and scientific research. Unfortunately, no scholar has yet addressed this field's bibliometric analysis and summary. We aim to comprehensively and profoundly study and explore the present situation and highlights of exosome research at the stage of respiratory diseases and to provide meaningful insights for the future development of this field. The WOSCC literature was gathered for the study using bibliometrics, and the data were collected and analyzed using CiteSpace, VOSviewer, Microsoft Excel, and Endnote software. The publication language is "English," and the search strategy is TS = (exosome OR exosomes OR exosomal) AND TS = (respiratory OR lung). The search time is from the beginning of the WOS construction, and the deadline is July 11, 2022, at 22:00 hours. The literature types selected were dissertation, review paper, and online published paper. The analysis includes 2456 publications in 738 journals from 76 countries, 2716 institutions, and 14,568 authors. The field's annual publications have been rising, especially in recent years. China and the US lead research, and prominent universities, including Harvard Medical School, Shanghai Jiao Tong University, and Fudan University, are essential research institutes. Takahiro Ochiya, whose research focuses on exosomes and lung cancer, and Clotilde Théry, a pioneering exosome researcher, are the most cited authors in this field. The key terms include lung cancer, non-small cell lung cancer, mesenchymal stem cells, intercellular communication, exosomal miRNAs, and oncology. Cell biology, biochemistry & biotechnology, and oncology are related fields. The final summary of research hotspots is exosomes and lung cancer, mesenchymal stem cell-derived exosomes and lung inflammation, and miRNAs in exosomes as biomarkers for respiratory illnesses. The present research situation and relevant hotspots of the area were analyzed through bibliometric studies on exosomes in respiratory diseases. The research development in this field has a considerable upside, and the exosome's function in diagnosing, treating, monitoring, and prognosis of respiratory illnesses cannot be taken lightly. Moreover, we believe the research results will bring the gospel to many patients with clinical respiratory diseases shortly.
Competing Interests: The authors have no conflicts of interest to disclose.
(Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.)
References: Am J Respir Crit Care Med. 2018 Jan 1;197(1):104-116. (PMID: 28853608)
Mol Aspects Med. 2018 Apr;60:92-103. (PMID: 29146100)
Nanomedicine (Lond). 2020 Dec;15(30):2933-2953. (PMID: 33241979)
Thorax. 2010 Nov;65(11):1016-24. (PMID: 20880880)
Thorax. 2019 Oct;74(10):965-976. (PMID: 31285360)
J Allergy Clin Immunol. 2013 Mar;131(3):894-903. (PMID: 23333113)
Cells. 2021 Mar 07;10(3):. (PMID: 33799966)
Nat Commun. 2015 Oct 07;6:8472. (PMID: 26442449)
Br J Cancer. 2015 Feb 3;112(3):532-8. (PMID: 25584485)
Adv Drug Deliv Rev. 2013 Mar;65(3):376-82. (PMID: 22841506)
Stem Cell Res Ther. 2018 Jan 29;9(1):17. (PMID: 29378639)
Lancet Respir Med. 2020 Jun;8(6):585-596. (PMID: 32526187)
Nat Rev Immunol. 2002 Aug;2(8):569-79. (PMID: 12154376)
J Thorac Oncol. 2013 Sep;8(9):1156-62. (PMID: 23945385)
AMIA Annu Symp Proc. 2005;:724-8. (PMID: 16779135)
Cancer Med. 2018 Oct;7(10):5118-5129. (PMID: 30256540)
Cells. 2019 Dec 11;8(12):. (PMID: 31835680)
Biochem Biophys Res Commun. 2017 Aug 19;490(2):406-414. (PMID: 28623135)
Stem Cells Transl Med. 2015 Nov;4(11):1302-16. (PMID: 26378259)
J Transl Med. 2005 Feb 21;3(1):9. (PMID: 15723705)
Biomed Res Int. 2015;2015:125807. (PMID: 26583084)
Diabetes Metab Syndr. 2022 Apr;16(4):102450. (PMID: 35344849)
Oncotarget. 2017 Feb 21;8(8):13048-13058. (PMID: 28055956)
Int J Nanomedicine. 2020 Jun 26;15:4453-4470. (PMID: 32617003)
Am J Respir Cell Mol Biol. 2020 Nov;63(5):623-636. (PMID: 32730709)
JCI Insight. 2019 Nov 1;4(21):. (PMID: 31581150)
J Transl Med. 2015 Sep 19;13:308. (PMID: 26386558)
Nat Med. 2001 Mar;7(3):297-303. (PMID: 11231627)
FASEB J. 2009 Jun;23(6):1858-68. (PMID: 19190083)
Front Cardiovasc Med. 2021 Aug 25;8:734514. (PMID: 34513962)
Sci Adv. 2017 Dec 15;3(12):e1701133. (PMID: 29291244)
J Extracell Vesicles. 2013 Jun 18;2:. (PMID: 24009892)
Front Cardiovasc Med. 2017 Oct 09;4:63. (PMID: 29062835)
J Extracell Vesicles. 2020 Jul 13;9(1):1790874. (PMID: 32939235)
Blood. 2007 Nov 1;110(9):3234-44. (PMID: 17666571)
PLoS One. 2014 Feb 21;9(2):e89534. (PMID: 24586853)
J Extracell Vesicles. 2015 Dec 31;4:30087. (PMID: 26725829)
Stem Cells Dev. 2020 Jun 15;29(12):747-754. (PMID: 32380908)
Int J Cancer. 2005 Feb 20;113(5):752-60. (PMID: 15499615)
Clin Cancer Res. 2017 Sep 1;23(17):5311-5319. (PMID: 28606918)
Nat Commun. 2018 Jan 15;9(1):191. (PMID: 29335551)
Crit Care Med. 2000 Nov;28(11):3722-7. (PMID: 11098980)
Nat Commun. 2018 Dec 19;9(1):5395. (PMID: 30568162)
Folia Histochem Cytobiol. 2021;59(4):203-211. (PMID: 34852180)
J Extracell Vesicles. 2015 Nov 11;4:28388. (PMID: 26563733)
J Am Soc Nephrol. 2013 Feb;24(3):385-92. (PMID: 23274427)
Nature. 2015 Nov 19;527(7578):329-35. (PMID: 26524530)
J Cell Biol. 2013 Feb 18;200(4):373-83. (PMID: 23420871)
Cancer Cell. 2016 Aug 8;30(2):243-256. (PMID: 27505671)
Scientometrics. 2010 Aug;84(2):523-538. (PMID: 20585380)
Stem Cells. 2014 Jan;32(1):116-25. (PMID: 23939814)
J Cell Biol. 1983 Aug;97(2):329-39. (PMID: 6309857)
J Transl Med. 2014 Jun 10;12:162. (PMID: 24912806)
Nat Cell Biol. 2007 Jun;9(6):654-9. (PMID: 17486113)
Int J Mol Sci. 2020 Jun 23;21(12):. (PMID: 32585976)
Nanomedicine. 2016 Apr;12(3):655-664. (PMID: 26586551)
J Biomed Nanotechnol. 2022 Mar 1;18(3):705-717. (PMID: 35715903)
J Extracell Vesicles. 2020 Jun 29;9(1):1785161. (PMID: 32944172)
Nature. 2005 Jun 9;435(7043):834-8. (PMID: 15944708)
Pharmaceutics. 2021 Nov 20;13(11):. (PMID: 34834387)
Int J Mol Sci. 2018 Aug 27;19(9):. (PMID: 30150544)
J Immunol. 2008 Oct 15;181(8):5242-8. (PMID: 18832678)
Mol Cancer. 2019 Jan 21;18(1):13. (PMID: 30665425)
Adv Sci (Weinh). 2023 Jul;10(19):e2206095. (PMID: 37144543)
Thorax. 2019 Mar;74(3):309-312. (PMID: 30244194)
Exp Mol Med. 2018 Apr 13;50(4):1-12. (PMID: 29650962)
Nat Rev Immunol. 2009 Aug;9(8):581-93. (PMID: 19498381)
Clin Lung Cancer. 2009 Jan;10(1):42-6. (PMID: 19289371)
Mediators Inflamm. 2016;2016:5628404. (PMID: 27738390)
Am J Respir Cell Mol Biol. 2004 Jul;31(1):114-21. (PMID: 14975938)
Nat Med. 2012 Jun;18(6):883-91. (PMID: 22635005)
Am J Respir Crit Care Med. 2015 Aug 1;192(3):324-36. (PMID: 26067592)
Am J Respir Cell Mol Biol. 2018 May;58(5):560-565. (PMID: 29115853)
Pediatr Res. 2018 Jan;83(1-2):298-307. (PMID: 28985201)
J Immunol. 2008 Jul 15;181(2):1519-25. (PMID: 18606707)
Nat Commun. 2019 Sep 24;10(1):4333. (PMID: 31551417)
Nat Commun. 2015 Apr 01;6:6716. (PMID: 25828099)
Inflamm Regen. 2020 Jun 22;40:14. (PMID: 32582401)
Mol Aspects Med. 2019 Dec;70:3-20. (PMID: 30102929)
Tumour Biol. 2016 Aug;37(8):10703-14. (PMID: 26867772)
Cancer Sci. 2006 Aug;97(8):689-96. (PMID: 16863503)
Expert Rev Anticancer Ther. 2005 Jun;5(3):537-47. (PMID: 16001959)
J Clin Med. 2018 Oct 14;7(10):. (PMID: 30322213)
Front Pharmacol. 2023 Mar 09;14:1082066. (PMID: 36969852)
Nat Rev Immunol. 2008 Sep;8(9):726-36. (PMID: 19172693)
Mol Cancer. 2019 Mar 13;18(1):40. (PMID: 30866952)
Eur Respir J. 2003 Oct;22(4):578-83. (PMID: 14582906)
Mol Ther. 2013 Jan;21(1):185-91. (PMID: 23032975)
Int J Nanomedicine. 2017 May 15;12:3721-3733. (PMID: 28553110)
Sci Rep. 2013;3:1197. (PMID: 23378928)
المشرفين على المادة: 0 (MicroRNAs)
تواريخ الأحداث: Date Created: 20230929 Date Completed: 20231004 Latest Revision: 20231004
رمز التحديث: 20231004
مُعرف محوري في PubMed: PMC10545307
DOI: 10.1097/MD.0000000000035381
PMID: 37773786
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-5964
DOI:10.1097/MD.0000000000035381